Skip to main content


22-09-2022 | EASD 2022 | Conference coverage | News

High-intensity exercise may be beneficial for people with impaired hypoglycemia awareness

Findings from the HIT4HYPOS trial suggest that a high-intensity exercise program may improve hormonal and symptomatic responses to hypoglycemia among people with type 1 diabetes and impaired awareness of hypoglycemia.

21-09-2022 | EASD 2022 | Conference coverage | News

Libre upgrade illustrates power of hypoglycemia alerts

Gaining the use of a low blood glucose alert by switching from the FreeStyle Libre 1 to 2 reduces the amount of time people with type 1 diabetes spend in hypoglycemia, report researchers.

20-09-2022 | EASD 2022 | Conference coverage | News

Freestyle Libre cuts acute complication risk in insulin-treated type 2 diabetes

People taking basal insulin to treat type 2 diabetes experience a significant reduction in the risk for acute complications, which is sustained for at least 2 years after initiating use of the Freestyle Libre, say French researchers.

20-06-2022 | Hypoglycemia | News

Hypoglycemia, rebound hyperglycemia disturbs LV function in type 1 diabetes

A randomized crossover trial shows that both hypoglycemia and rebound hyperglycemia trigger persistent increases in left ventricular function in people with type 1 diabetes.

15-06-2022 | Insulin | News

Liver-targeted insulin reduces hypoglycemic events

Switching 1% of standard bolus insulin lispro to a liver-targeted formulation decreases hypoglycemic events without affecting glucose control, OPTI-1 study findings indicate.

08-06-2022 | ADA 2022 | Conference coverage | News

Overnight glycemic variability may impact next day function

Fluctuations in blood glucose levels during the night can adversely impact the psychologic and physical function of people with type 1 diabetes during the following day, report researchers.

07-06-2022 | ADA 2022 | Conference coverage | News

Stem cell approach shows promise for unstable type 1 diabetes

Early results suggest that transplantation of fully differentiated stem cell-derived islet cells is a promising approach for achieving glycemic control in people with unstable type 1 diabetes.

06-06-2022 | ADA 2022 | Conference coverage | News

​​​​​​​Hypoglycemia risk from insulin overdose no worse with icodec than glargine

The risk for hypoglycemia from an accidental basal insulin overdose is no higher with weekly insulin icodec than with daily glargine U100 in people with type 2 diabetes, report researchers.